Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

"After Losing My Father to Cancer, I Vowed to Develop CAR-T Therapy"

Summary by 조선일보
Curocell CEO Kim Gun-soo, a bio-venture founded based on his father's experience battling illness, presented the process of developing Limcato, the first CAR-T therapy in Korea, and obtaining approval as the 42nd domestic new drug, as well as a vision for the future development of solid tumor treatments.

1 Articles

Lean Right

Curocell CEO Kim Gun-soo, a bio-venture founded based on his father's experience battling illness, presented the process of developing Limcato, the first CAR-T therapy in Korea, and obtaining approval as the 42nd domestic new drug, as well as a vision for the future development of solid tumor treatments.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

조선일보 broke the news on Tuesday, August 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal